Martin Mackay - Jul 29, 2021 Form 3 Insider Report for Rallybio Corp (RLYB)

Role
Chief Executive Officer, Director
Signature
By: /s/ Michael Greco, Attorney-in-Fact
Stock symbol
RLYB
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
3
Date filed
7/29/2021, 07:34 PM
Previous filing
Jan 12, 2022
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RLYB Common Stock 273K Jul 29, 2021 Direct
holding RLYB Common Stock 437K Jul 29, 2021 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RLYB Option (Right to Buy) Jul 29, 2021 Common Stock 160K $13.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock are held directly by a limited liability company, of which Martin Mackay is the managing member. As a result, Dr. Mackay may be deemed to share beneficial ownership of the shares held by the limited liability company.
F2 The option vests as to 25% of the underlying shares of Common Stock on July 28, 2022 and as to the remaining 75% of the underlying shares of Common Stock in 36 equal monthly installments thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney